Maternal Fetal Medicine by Dr. Turk

This podcast outlines clinical guidelines for managing opioid use disorder during pregnancy. We emphasize the necessity of universal screening at the first prenatal visit using validated verbal tools to identify patients regardless of their background. Opioid agonist pharmacotherapy, specifically with methadone or buprenorphine, is recommended over medically supervised withdrawal to prevent relapse and improve maternal-fetal outcomes. Medical providers are encouraged to adopt a multidisciplinary care approach that addresses mental health, infectious disease testing, and neonatal monitoring for withdrawal symptoms. Ultimately, we advocate for supportive medical interventions rather than criminal sanctions to ensure the safety of both the mother and the infant.

This podcast article examines the clinical management of nonobstetric surgery during pregnancy, a situation affecting approximately 1%–2% of expectant mothers. The podcast evaluate global guidelines from major medical societies to provide a consensus on preoperative imaging, anesthesia, and surgical techniques. Digestion-related issues like appendectomy and cholecystectomy are identified as the most frequent reasons for intervention, though such procedures carry inherent risks like prematurity and neonatal complications. To mitigate these risks, the podcast emphasizes strategic planning, including the use of MRI without gadolinium and specific patient positioning to prevent cardiovascular strain. Furthermore, the podcast highlights the safety of laparoscopic approaches and modern anesthetics when administered through a multidisciplinary framework. Ultimately, the source advocates for evidence-based decision-making and precise surgical timing, typically during the second trimester, to optimize health outcomes for both the mother and the fetus.

The provided podcast details the inpatient management of hyperemesis gravidarum (HG), a severe form of pregnancy-related nausea that can lead to dehydration, electrolyte imbalances, and significant maternal morbidity. Effective hospital care begins with aggressive rehydration and nutritional repletion, specifically utilizing intravenous thiamine to prevent neurological complications like Wernicke encephalopathy. The podcast outlines a tiered pharmacotherapeutic approach, moving from standard antiemetics and acid-reducers to alternative medications such as mirtazapine, olanzapine, and gabapentin for refractory cases. When medications fail to curb weight loss, enteral or parenteral nutrition may be necessary, though these carry risks like infection and thrombosis that require careful patient counseling. Ultimately, the podcast emphasizes a transition to a structured outpatient regimen to ensure a safe discharge and minimize the high likelihood of hospital readmission.

This podcast outlines the comprehensive evaluation and management of non-immune hydrops fetalis (NIHF), a condition where pathological fluid accumulates in at least two fetal compartments. Genetic disorders and structural anomalies are the primary causes, and advanced diagnostic testings like chromosomal microarray and exome sequencing are prerequisite. Clinicians are advised to monitor for maternal risks, particularly mirror syndrome, which mimics severe preeclampsia and may necessitate urgent delivery. Management strategies should be highly individualized, incorporating multidisciplinary counseling to address potential fetal therapies or palliative care. Ultimately, the guidelines prioritize shared decision-making regarding the timing and mode of delivery based on the underlying etiology and the pregnant person's preferences.

This podcast explores vasa previa, a dangerous obstetric condition where unprotected fetal blood vessels traverse the membranes near the cervix, risking lethal hemorrhage during labor. While historically linked to high perinatal mortality, the text emphasizes that prenatal diagnosis via ultrasonography has transformed the prognosis, leading to excellent survival rates through planned cesarean deliveries. This podcast identifies key risk factors, such as in vitro fertilization and low-lying placentas, advocating for targeted screening to prevent accidental vessel rupture. Management strategies discussed include the timing of delivery, the utility of cervical length measurements, and the ongoing debate regarding routine hospitalization versus outpatient care. Furthermore, it examines innovative treatments like fetoscopic laser ablation, which may eventually allow some patients to avoid preterm surgery. Ultimately, the podcast underscores that while vasa previa is rare, its life-threatening complications are almost entirely preventable with early detection and proactive clinical management.

Immune thrombocytopenia (ITP) is a complex autoimmune disorder characterized by low platelet counts, which presents significant clinical challenges when it occurs during pregnancy. This podcast discusses how the condition is driven by antiplatelet antibodies that can cross the placenta, potentially affecting both maternal health and fetal development. Distinguishing ITP from more common conditions like gestational thrombocytopenia is essential for determining the appropriate medical response and monitoring schedule. Standard treatments typically involve prednisone and intravenous immune globulin, though newer options like thrombopoietin-receptor agonists are increasingly considered for difficult cases. Management requires a coordinated team of specialists to balance the risks of hemorrhage against the safety of medications during gestation and delivery. Ultimately, while ITP complicates pregnancy, careful risk assessment and individualized therapy usually lead to successful outcomes for both mother and child.

This podcast outlines essential anticoagulation protocols for pregnant individuals with cardiac conditions. It specifically highlights the high mortality risks associated with mechanical heart valves, necessitating a complex balance between preventing maternal valve thrombosis and avoiding fetal complications like warfarin embryopathy. The podcast provides detailed instructions for transitioning between warfarin, low-molecular-weight heparin, and unfractionated heparin during different trimesters and the peripartum period. It emphasizes multidisciplinary care involving cardiology and anesthesiology to ensure safe delivery and postpartum recovery. Specialized recommendations regarding emergency reversal, contraception, and surgical interventions are also included to assist clinicians in managing these high-risk patients.

This podcast examines the management of neurocutaneous disorders during pregnancy, specifically focusing on conditions like Neurofibromatosis (Types 1 and 2), Tuberous Sclerosis Complex, Sturge-Weber syndrome, and Von Hippel–Lindau syndrome. The podcast highlights that these rare genetic conditions often lead to increased maternal and neonatal morbidity, including hypertensive disorders, seizures, and accelerated tumor growth due to hormonal shifts. To mitigate risks such as preterm labor or neurological deterioration, we advocate for a multidisciplinary care team involving maternal-fetal medicine specialists, neurologists, and anesthesiologists. Preconception counseling, genetic testing, and frequent imaging are emphasized as vital components for optimizing health outcomes. Ultimately, the source provides a clinical framework for obstetricians to navigate the complex physiological interactions between these systemic disorders and the demands of pregnancy.

This podcast regarding cell-free DNA (cfDNA) screening for fetal chromosomal abnormalities. It establishes that cfDNA is the most accurate screening method for common trisomies and should be offered to all pregnant patients regardless of their risk level. The text explains the biological mechanisms behind the technology, such as the analysis of placental DNA fragments, while highlighting the necessity of pretest counseling to manage expectations. Specialized sections address the complexities of screening for sex chromosome aneuploidies, microdeletions, and conditions in twin gestations. Furthermore, the guidelines assist clinicians in interpreting inconclusive results and navigating unexpected findings that may indicate maternal health issues. Overall, the source emphasizes that while cfDNA is a powerful tool, it remains a screening test that requires diagnostic confirmation for definitive results.

This podcast provides a comprehensive clinical guide for managing sickle cell disease (SCD) during pregnancy, emphasizing that this population faces significantly higher risks of maternal and perinatal mortality. To improve outcomes, the experts recommend a multidisciplinary care team consisting of hematologists, genetics counselors, and pain management specialists. Key clinical protocols include aggressive fetal growth surveillance starting at 28 weeks, specialized vaccination schedules, and tailored pain management strategies that balance maternal well-being with neonatal withdrawal risks. The guide also addresses the cautious use of disease-modifying therapies like hydroxyurea and the necessity of individualized transfusion plans for high-risk patients. Furthermore, the document highlights the impact of structural racism on SCD healthcare and advocates for shared decision-making regarding reproductive options and contraception. Ultimately, the source serves as an evidence-based framework to navigate the complex physiological and pharmacological challenges inherent in high-risk obstetric care for those with SCD.

This podcast examines the complex relationship between chronic kidney disease (CKD) and pregnancy, emphasizing that renal dysfunction significantly increases the risk of adverse maternal and neonatal outcomes. This podcast explains how normal anatomic and physiologic adaptations to pregnancy can complicate the diagnosis and management of underlying kidney issues. Key risks identified include higher rates of preeclampsia, preterm delivery, and fetal growth restriction, all of which worsen as the disease progresses. To mitigate these dangers, the text advocates for multidisciplinary care involving both obstetricians and nephrologists to manage hypertension and proteinuria. The source also provides specific guidance for the most vulnerable populations, such as those requiring dialysis or living with a kidney transplant. Finally, it outlines essential safety protocols, including the avoidance of teratogenic medications and the implementation of preventative strategies like low-dose aspirin.

This podcast provides clinical guidance regarding cesarean scar ectopic pregnancy (CSEP), a dangerous condition where an embryo implants in the scar of a previous cesarean delivery. Because CSEP carries high risks for maternal morbidity and mortality, the authors emphasize the necessity of early diagnosis primarily through transvaginal ultrasound. The guidelines strongly recommend against expectant management due to the likelihood of severe complications like uterine rupture or massive hemorrhage. Instead, they suggest surgical resection or ultrasound-guided aspiration, while cautioning that systemic methotrexate should not be used as a standalone treatment. The text concludes by advising patients on the high risk of recurrence in future pregnancies and the importance of effective contraception for those who have experienced this condition.

This podcast addresses the alarming resurgence of syphilis and congenital syphilis in the United States. The text outlines the pathophysiology and clinical stages of the infection, highlighting its devastating impact on pregnancy, including risks of stillbirth and neonatal death. It provides a comprehensive guide for obstetrician–gynecologists on modern diagnostic methods, comparing traditional and reverse screening algorithms. Furthermore, the source emphasizes the necessity of penicillin G as the primary treatment and discusses the management of the Jarisch-Herxheimer reaction. Finally, it underscores the importance of public health reporting and addressing socioeconomic barriers to care to mitigate this growing crisis.

This document provides comprehensive guidelines for managing Hepatitis B during pregnancy to improve maternal health and prevent newborn transmission. The authors recommend universal triple-panel screening at the first prenatal visit to identify infection, immunity, or susceptibility in all patients. For those with a high viral load, the guide suggests using antiviral medications like tenofovir during the third trimester as an additional safeguard. It emphasizes that immunoprophylaxis for infants and vaccination for non-immune adults are critical, safe, and cost-effective tools. Furthermore, the report clarifies that common practices like breastfeeding and vaginal delivery are generally safe for infected individuals provided the infant receives immediate medical care. Consistent monitoring and specialist referrals remain essential for long-term health and the prevention of chronic liver complications.

This clinical review examines pregnancy dermatoses, a diverse group of inflammatory skin conditions that emerge during or shortly after gestation. The authors categorize these disorders into five primary types: pempigoid gestationis, polymorphic eruption of pregnancy, intrahepatic cholestasis of pregnancy, atopic eruption of pregnancy, and pustular psoriasis of pregnancy. Each condition is analyzed based on its epidemiology, clinical presentation, and diagnostic criteria, emphasizing the distinction between benign rashes and those carrying significant maternal and fetal risks. The text highlights that while some eruptions are merely symptomatic, others—such as cholestasis—require urgent medical intervention to prevent complications like stillbirth or premature labor. Consequently, the source serves as a comprehensive guide for clinicians to improve recognition and management of these unique dermatological challenges. The overview concludes by detailing first-line treatments, ranging from topical corticosteroids to specialized oral medications, ensuring tailored care for pregnant patients.

This clinical overview examines the complex relationship between inflammatory bowel disease (IBD) and pregnancy, emphasizing that maintaining disease remission is the most critical factor for healthy outcomes. The authors highlight that while active inflammation increases the risk of complications like preterm birth and low birth weight, most maintenance medications, including biologics, are safe and should be continued. Preconception counseling is recommended to address patient concerns regarding fertility and the safety of nursing while on treatment. The text also provides specific guidance on diagnostic imaging, the safety of various drug classes, and delivery methods, noting that vaginal birth is generally appropriate unless active perianal disease is present. Ultimately, a multidisciplinary approach involving gastroenterologists and obstetricians is presented as the gold standard for managing IBD during the reproductive years.

This podcast provides a comprehensive overview of acute fatty liver of pregnancy (AFLP), a rare but life-threatening condition typically occurring in the third trimester. The authors trace the historical understanding of the disease and explain how fetal fatty acid oxidation defects contribute to maternal liver failure. A significant portion of the text focuses on diagnostic strategies, specifically using the Swansea criteria and laboratory markers to distinguish AFLP from similar disorders like HELLP syndrome. The sources emphasize that prompt delivery and intensive supportive care are the primary treatments for managing multi-organ complications. Finally, the material outlines the expected recovery timeline for hepatic and renal functions while noting that modern interventions have successfully reduced maternal mortality rates.